Ms. Milena Izmirlieva is head of the Life Sciences research team at IHS.
Milena Izmirlieva heads the IHS Life Sciences research team, which includes senior analysts, analysts and health economists covering both developed and emerging markets worldwide. She joined IHS Global Insight in 2003 as a Research Analyst in the Pharma Practice for Western European and Central and Eastern European markets and became a Senior Analyst, covering North America, in 2006 and Project Manager in charge of IHS Global Insight's Generics Analysis service in 2008. Milena has previously worked as a freelance healthcare analyst for IMS Health London, and has four years' experience in healthcare marketing communications for the EURO RSCG group in New York (U.S.) and Sofia (Bulgaria) where she worked with both pharmaceutical and medical device companies. She holds a Master of Science degree in Communication with a focus on Science Writing from Iowa State University and a joint BA degree in Journalism and Mass Communication and International Relations from the American University in Bulgaria. Milena is a regular speaker at pharmaceutical conferences and is often interviewed about pharmaceutical-related issues in the media. She regularly presents peer-reviewed research at ISPOR and has a strong interest in pharmaceutical pricing and reimbursement developments and cost-containment strategies (including international reference pricing). Milena is a Fulbright scholarship recipient and member of the following honour societies: Phi Kappa Phi, Alfa Delta Sigma, and Kappa Tau Alfa.